Cadrenal Therapeutics (Nasdaq: CVKD) Announces Closing of Initial Public Offering
/PRNewswire/ -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company focused on developing tecarfarin, a clinical-stage novel cardiorenal...
Stay updated with breaking news from Keith Moore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company focused on developing tecarfarin, a clinical-stage novel cardiorenal...
Pickering Interfaces of Clacton-on-sea has announced the company’s formal approach to protecting customers from one of the most expensive challenges test
January, 2023 – Clacton-on-Sea, UK – Pickering Interfaces, a critical supplier of modular signal switching and simulation solutions for use in electronic test and verification, today announced the company’s formal approach to protecting customers from one of the most expensive challenges test engineers face when maintaining automated test equipment (ATE) – obsolescence. “Mission-critical products with long…
/PRNewswire/ -- Cadrenal Therapeutics, Inc., a biopharmaceutical company focused on developing tecarfarin, a clinical-stage novel cardiorenal therapy with...
According to Earth system scientists at the University of California, Irvine, climate-driven seawater heating is slowing down deep circulation patterns in the Atlantic and Southern oceans.